Pingping Zhong1, Jifeng Li2, Yiqun Gu1, Yu Liu3, Aichun Wang1, Yunfei Sun1, Lijuan Lu1. 1. Department of Pathology, Haidian Maternal & Child Health Hospital Beijing, P. R. China. 2. Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University Beijing, P. R. China. 3. Department of Pathology, Capital Medical University Beijing, P. R. China.
Abstract
OBJECTIVE: To determine the association between the expression of p16 and Ki-67 and cervical lesions, and to evaluate the role of p16 and Ki-67 as prognostic markers for persistent high risk human papillomavirus (hr-HPV) infection. METHODS: Totally 1,154 cases of cervical biopsies were enrolled, 331 cases with negative for dysplasia (NEG), 462 with cervical intraepithelial neoplasia 1 (CIN1), 176 with CIN2, 163 with CIN3 and 22 with cervical squamous cell carcinoma (SCC). Furthermore, 283 women with CIN1 were recruited into 12-month follow-up, and HPV specific gene detection by polymerase chain reaction was used to detect hr-HPV of cervical secretions at 6-month-interval for 12-month follow-up period. 40 women were infected with persistent hr-HPV, 182 with transient infection and 61 unfected with hr-HPV. The expression of p16 and Ki-67 were evaluated by immunohistochemical method. The immunostaining results of p16 and Ki-67 were classified into four categories: negative, 1+, 2+ and 3+. RESULTS: There was significant increase in the expression of p16 (P<0.001) and Ki-67 (P<0.001) from NEG to SCC. The expression of Ki-67 (P<0.001) but not p16 (P=0.254) significantly increased in CIN2, CIN3. Ratio of p16 (P=0.215) and Ki-67 (P=0.495) positivity were not correlated with persistent hr-HPV infection. CONCLUSION: P16 and Ki-67 can improve the diagnostic accuracy of cervical lesions but can not predict persistent hr-HPV infection with CIN1.
OBJECTIVE: To determine the association between the expression of p16 and Ki-67 and cervical lesions, and to evaluate the role of p16 and Ki-67 as prognostic markers for persistent high risk human papillomavirus (hr-HPV) infection. METHODS: Totally 1,154 cases of cervical biopsies were enrolled, 331 cases with negative for dysplasia (NEG), 462 with cervical intraepithelial neoplasia 1 (CIN1), 176 with CIN2, 163 with CIN3 and 22 with cervical squamous cell carcinoma (SCC). Furthermore, 283 women with CIN1 were recruited into 12-month follow-up, and HPV specific gene detection by polymerase chain reaction was used to detect hr-HPV of cervical secretions at 6-month-interval for 12-month follow-up period. 40 women were infected with persistent hr-HPV, 182 with transient infection and 61 unfected with hr-HPV. The expression of p16 and Ki-67 were evaluated by immunohistochemical method. The immunostaining results of p16 and Ki-67 were classified into four categories: negative, 1+, 2+ and 3+. RESULTS: There was significant increase in the expression of p16 (P<0.001) and Ki-67 (P<0.001) from NEG to SCC. The expression of Ki-67 (P<0.001) but not p16 (P=0.254) significantly increased in CIN2, CIN3. Ratio of p16 (P=0.215) and Ki-67 (P=0.495) positivity were not correlated with persistent hr-HPV infection. CONCLUSION:P16 and Ki-67 can improve the diagnostic accuracy of cervical lesions but can not predict persistent hr-HPV infection with CIN1.
Authors: Eleanor Y Chen; Ann Tran; Caroline J Raho; Chandler M Birch; Christopher P Crum; Michelle S Hirsch Journal: Mod Pathol Date: 2010-05-14 Impact factor: 7.842
Authors: Ana Cecilia Rodríguez; Alfonso J García-Piñeres; Allan Hildesheim; Rolando Herrero; Matthew Trivett; Marcus Williams; Ivannia Atmella; Margarita Ramírez; Maricela Villegas; Mark Schiffman; Robert Burk; Enrique Freer; José Bonilla; Concepción Bratti; Ligia A Pinto Journal: Int J Cancer Date: 2011-02-01 Impact factor: 7.396
Authors: M Branca; M Ciotti; D Santini; L Di Bonito; C Giorgi; A Benedetto; P Paba; C Favalli; S Costa; A Agarossi; M Alderisio; K Syrjänen Journal: Int J Gynecol Pathol Date: 2004-10 Impact factor: 2.762
Authors: G Y Ho; R D Burk; S Klein; A S Kadish; C J Chang; P Palan; J Basu; R Tachezy; R Lewis; S Romney Journal: J Natl Cancer Inst Date: 1995-09-20 Impact factor: 13.506
Authors: Maria Teresa Roncaglia; José Humberto T G Fregnani; Maricy Tacla; Silvana Gisele Pegorin DE Campos; Hélio Hehl Caiaffa; Alexandre Ab'saber; Eduardo Vieira DA Motta; Venâncio Avancini Ferreira Alves; Edmund C Baracat; Adhemar Longatto Filho Journal: Oncol Lett Date: 2013-05-20 Impact factor: 2.967
Authors: Christine J McGrath; Rochelle Garcia; Trong T Trinh; Barbra A Richardson; Grace C John-Stewart; Evans Nyongesa-Malava; Nelly R Mugo; Emily H Glynn; Samah R Sakr; Hugo De Vuyst; Michael H Chung Journal: PLoS One Date: 2017-10-12 Impact factor: 3.240
Authors: Hina Sarwath; Devendra Bansal; Nazik Elmalaika Husain; Mahmoud Mohamed; Ali A Sultan; Shahinaz Bedri Journal: Infect Agent Cancer Date: 2017-09-30 Impact factor: 2.965